Morgan Dempsey Capital Management’s West Pharmaceutical WST Stock Holding History

Morgan Dempsey Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-14	Closed	-$3.06K	–	164
2025 Q2	$3.06K	Hold	14	–	–	﹤0.01%	149
2025 Q1	$3.13K	Hold	14	–	–	﹤0.01%	134
2024 Q4	$4.59K	Hold	14	–	–	﹤0.01%	119
2024 Q3	$4.2K	Hold	14	–	–	﹤0.01%	123
2024 Q2	$4.61K	Hold	14	–	–	﹤0.01%	108
2024 Q1	$5.54K	Hold	14	–	–	﹤0.01%	109
2023 Q4	$4.93K	Hold	14	–	–	﹤0.01%	119
2023 Q3	$5.25K	Hold	14	–	–	﹤0.01%	113
2023 Q2	$5.36K	Hold	14	–	–	﹤0.01%	114
2023 Q1	$4.85K	Hold	14	–	–	﹤0.01%	119
2022 Q4	$3.29K	Hold	14	–	–	﹤0.01%	146
2022 Q3	$3K	Buy	+14	New	+$4.26K	﹤0.01%	162
2018 Q3	–	Sell	-42	Closed	-$4K	–	158
2018 Q2	$4K	Buy	+42	New	+$3.87K	﹤0.01%	157

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Morgan Dempsey Capital Management's WST Position: Q3 2025 in Review

Morgan Dempsey Capital Management sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 14 shares — an estimated $3.06K sold.

Morgan Dempsey Capital Management first reported a position in WST in Q2 2018 and held it in 13 quarters. The position peaked at $5.54K in Q1 2024. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

Morgan Dempsey Capital Management reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
Morgan Dempsey Capital Management sold 14 West Pharmaceutical shares in Q3 2025, an estimated $3.06K.
Morgan Dempsey Capital Management first reported a position in West Pharmaceutical in Q2 2018 and held it in 13 quarters.
Morgan Dempsey Capital Management's West Pharmaceutical position peaked at $5.54K in Q1 2024.
758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Morgan Dempsey Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.